Doctor profile · Federal record
Dr. MICHELLE ASZTERBAUM, MD
Dermatology Physician (CMS: DERMATOLOGY) · NEWPORT BEACH, CA
- NPI 1992891329
- Accepts Medicare
- MIPS 91.2 / 100 · 2023
- 33 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1441 AVOCADO AVE STE 807
NEWPORT BEACH, CA 926607709
(949) 525-0700
fax (866) 299-5012 - Additional location
-
1441 Avocado Ave Ste 806
Newport Beach, CA 926607709
(949) 718-1222
fax (949) 718-1220
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- July 21, 2022
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- California #G81356
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992891329. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,869
Distinct HCPCS
10
Medicare allowed
$493,195
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 2,750 | 12 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 2,397 | 350 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,041 | 593 | $141 | |
17000 |
Destruction of precancer skin growth, 1 growth | 706 | 447 | $55 | |
11102 |
Biopsy of related skin growth, first growth | 391 | 309 | $100 | |
17110 |
Destruction of skin growth, 1-14 growths | 361 | 278 | $128 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 229 | 188 | $99 | |
11103 |
Biopsy of related skin growth, each additional growth | 113 | 79 | $58 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 102 | 102 | $124 | |
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 95 | 66 | $40 |
In context: peer comparison
Among 16 peers in this city , average services per provider: 505. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$721
Transactions
25
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 5 | $207.30 | |
| Incyte Corporation | 2 | $89.55 | |
| ABBVIE INC. | 4 | $88.50 | |
| GENZYME CORPORATION | 2 | $73.87 | |
| Amgen Inc. | 3 | $66.94 | |
| Arcutis Biotherapeutics, Inc. | 3 | $60.51 | |
| Organogenesis Inc. | 2 | $51.03 | |
| Journey Medical Corporation | 1 | $24.84 | |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24.64 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23.57 | |
| Biofrontera Inc. | 1 | $9.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
517
Patients
319
Total drug cost
$21,988
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Mometasone Furoate | Generic | 57 | 49 | $1,445 |
| Triamcinolone Acetonide | Generic | 56 | 34 | $531 |
| Clobetasol Propionate | Generic | 55 | 41 | $4,264 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 51 | 30 | $1,297 |
| Ketoconazole | Generic | 47 | 27 | $810 |
| Mupirocin | Generic | 42 | 30 | $362 |
| Betamethasone Dipropionate | Generic | 39 | 25 | $1,772 |
| Fluorouracil | Generic | 30 | 28 | $2,968 |
| Minoxidil | Generic | 27 | 0 | $159 |
| Doxycycline Hyclate | Generic | 25 | 13 | $769 |